4//SEC Filing
Arnold Susan Elizabeth 4
Accession 0001169245-20-000081
CIK 0001169245other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 9:08 PM ET
Size
10.2 KB
Accession
0001169245-20-000081
Insider Transaction Report
Form 4
Arnold Susan Elizabeth
VP, Preclinical and Chem.
Transactions
- Exercise/Conversion
Common Stock
2020-10-01$1.15/sh+5,423$6,236→ 13,152 total - Exercise/Conversion
Common Stock
2020-02-27$1.15/sh+5,423$6,236→ 7,729 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-02-27$1.15/sh−5,423$6,236→ 0 totalExercise: $1.15From: 2014-03-01Exp: 2020-03-01→ Common Stock (5,423 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2020-10-01$1.15/sh−5,423$6,236→ 0 totalExercise: $1.15From: 2014-10-01Exp: 2020-10-01→ Common Stock (5,423 underlying)
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001755746
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 9:08 PM ET
- Size
- 10.2 KB